By Thursday it had been detected in at least 52 countries and regions.
“While EG.5 has shown increased prevalence, growth advantage, and immune escape properties, there have been no reported changes in disease severity to date. The public health risk posed by EG.5 is evaluated as low at the global level,” the WHO said.